Velanne Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-56,875
Closed -$5.91M 19
2020
Q3
$5.91M Sell
56,875
-55,227
-49% -$5.55M 4.39% 14
2020
Q2
$10.3M Sell
112,102
-3,302
-3% -$317K 7.85% 3
2020
Q1
$10.4M Buy
115,404
+11,198
+11% +$1.19M 9.51% 2
2019
Q4
$11.8M Buy
104,206
+49
+0% +$5.38K 6.97% 3
2019
Q3
$11.3M Buy
104,157
+5,175
+5% +$540K 7.24% 3
2019
Q2
$9.64M Buy
98,982
+1,583
+2% +$145K 6.13% 5
2019
Q1
$8.87M Buy
97,399
+3,836
+4% +$343K 6.13% 4
2018
Q4
$8.51M Buy
+93,563
New +$8.74M 6.8% 5

Other funds holding MDT

Velanne Asset Management's MDT Position: Q4 2020 in Review

Velanne Asset Management sold out of Medtronic (MDT) in Q4 2020, closing a stake of 56,875 shares — an estimated $5.91M sold.

Velanne Asset Management first reported a position in MDT in Q4 2018 and held it in 8 quarters. The position peaked at $11.8M in Q4 2019. 1,957 funds tracked by Wall St. Rank hold MDT as of Q4 2020.

  • Velanne Asset Management reported no remaining Medtronic position as of Q4 2020 after selling out during the quarter.
  • Velanne Asset Management sold 56,875 Medtronic shares in Q4 2020, an estimated $5.91M.
  • Velanne Asset Management first reported a position in Medtronic in Q4 2018 and held it in 8 quarters.
  • Velanne Asset Management's Medtronic position peaked at $11.8M in Q4 2019.
  • 1,957 funds tracked by Wall St. Rank held Medtronic as of Q4 2020.

Based on Velanne Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.